News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bio-Path Holdings, Inc. (BPTH) Appoints Ulrich W. Mueller Chief Operating Officer


3/26/2014 7:21:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Dr. Ulrich W. Mueller has joined the Company as Chief Operating Officer. Dr. Mueller will be responsible for the Company’s drug development, licensing and intellectual property activities, including managing the Company’s clinical trials, pre-clinical and research and development efforts.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES